When it comes to drug pricing, the Trump and Biden-Harris administrations both have some very modest wins to tout. As director of the Health Outcomes, Policy, and Evidence Synthesis group at the University of Connecticut School of Pharmacy, I teach and study about the ethics of prescription drug prices and the complexities of drug pricing nationally. Delving into the presidential candidates’
